, Tracking Stock Market Picks
Enter Symbol:
Arqule, Inc. (ARQL) [hlAlert]

down 51.38 %

Arqule, Inc. (ARQL) upgraded to Buy with price target $7 by Banc of America Sec

Posted on: Wednesday,  Sep 3, 2008  9:25 AM ET by Banc of America Sec

Banc of America Sec rated Buy Arqule, Inc. (NASDAQ: ARQL) on 09/03/2008, when the stock price was $3.62.
Since then, Arqule, Inc. has lost 51.38% as of 01/22/2016's recent price of $1.76.
If you would have followed this Banc of America Sec's recommendation on ARQL, you would have lost 51.38% of your investment in 2697 days.

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.

Integrity, objectivity and originality are cornerstones of the value–added research that we offer to corporate and institutional clients. As thought leaders, our goal is to help clients understand and adapt to changing economic conditions and events that drive markets, currencies, industries and companies worldwide. And we deliver innovative ideas based on rigorous primary research, sound principles and clear vision. Our research teams are organized by areas of expertise, from equities, fixed income and emerging markets to foreign exchange and global financial risk advisory – featuring many of the industry’s most respected analysts and economists. Through our private, password–protected Web portal, our clients have access to a comprehensive array of timely research and commentary, including: * U.S. and global economic updates and indicators * Federal budget and fiscal policy * Industry outlooks * Stock coverage and picks * Financial market strategies * Corporate bond issuer risk analysis
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/3/2008 9:25 AM Buy
3.62 7.00
as of 12/24/2008
1 Week down  -8.22 %
1 Month down  -2.36 %
3 Months up  5.62 %
1 YTD down  -2.13 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/9/2008 8:25 AM Hold
4.59 6.00
12/4/2007 9:25 AM Buy
6.57 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy